The Biotech Startups Podcast
🧬 Nathan Clark - Ganymede - Part 2 | Moving from Goldman Sachs to Fintech | Exploring Product Management at Affirm | Leveraging Data & Building Tech Solutions| Impacting Scientific Progress at Benchling
July 18, 2024
Part 2 of 4. My guest for this week’s episode is Nathan Clark, Founder and CEO of Ganymede. Ganymede is the modern cloud data platform for the life sciences and manufacturing. Their Lab-as-Code technology allows you to quickly integrate and harmonize lab instruments and app data, automate analysis, visualize all your data in dashboards built over a powerful data lake, and ultimately speed up your operations to accelerate science or production.
Part 2 of 4. 

My guest for this week’s episode is Nathan Clark, Founder and CEO of Ganymede. Ganymede is the modern cloud data platform for the life sciences and manufacturing. Their Lab-as-Code technology allows you to quickly integrate and harmonize lab instruments and app data, automate analysis, visualize all your data in dashboards built over a powerful data lake, and ultimately speed up your operations to accelerate science or production.

Prior to founding Ganymede, Nathan was Product Manager for several of Benchling's data products, including the Insights BI tool and Machine Learning team. Before Benchling, Nathan worked at Affirm as a Senior Product Manager and was also a Trader at Goldman Sachs.

Join us this week and hear about:


Nathan’s extensive background in machine learning and data systems across financial and lab technology and knowledge of their applications in the life sciences offers unique insights for founders to benefit from. Please enjoy my conversation with Nathan Clark.

Timestamps:
00:00 Intro: Recap & Episode Overview
01:51 Nathan's realization at Goldman Sachs; transitioning to Affirm
04:05 Discussion on securitization and capital markets
06:28 Differences between Fintech and Wall Street
10:31 Nathan’s introduction to product management and data infrastructure
14:18 Understanding user needs; aligning product development with real-world problems
18:14 Nathan’s decision to leave Affirm
19:35 Frustration with scientific progress; wanting to help accelerate Biology research
24:28 Joining Benchling: new responsibilities and experiences
26:33 Outro

Find Our Guest, Nathan Clark, at these links: 
https://www.linkedin.com/in/nathan-clark-4b850134/
https://www.ganymede.bio/

Find Our Host, Jon Chee, at these links: 
https://www.linkedin.com/in/jonchee
https://www.excedr.com

Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/ 
Youtube: https://www.youtube.com/@excedr 
Instagram: https://www.instagram.com/excedr_inc 
Twitter: https://twitter.com/ExcedrInc 
Facebook: https://www.facebook.com/excedr 
TikTok: https://www.tiktok.com/@excedr 
Podcast Website: https://www.thebiotechstartupspodcast.com/ 

Enriched Notes:

Topics Mentioned:
Goldman Sachs https://www.goldmansachs.com/
Affirm https://www.affirm.com/
UC Berkeley https://www.berkeley.edu/
Benchling https://www.benchling.com/
Collateralized Loan Obligations (CLOs) https://www.investopedia.com/terms/c/clo.asp
Capital Markets https://www.stlouisfed.org/education/tools-for-enhancing-the-stock-market-game-invest-it-forward/episode-1-understanding-capital-markets
Securitizations https://www.investopedia.com/terms/s/securitization.asp
Product Management 101 https://www.atlassian.com/agile/product-management
Moore's Law https://en.wikipedia.org/wiki/Moore%27s_law
Automated Liquid Handling https://www.excedr.com/blog/guide-to-automated-liquid-handling
Funding Markets & Stages https://visible.vc/blog/startup-funding-stages/
Product-Market Fit & Solving a Problem https://stripe.com/resources/more/what-is-product-market-fit-what-startups-need-to-know
The Slowing of Scientific Progress https://phys.org/news/2023-01-scientific-breakthroughs.html
Cost of Developing a New Drug https://vial.com/blog/articles/drug-development-costs-explained-why-is-it-so-expensive/
 
People Mentioned:
Patrick Collison (Founder of Stripe) https://en.wikipedia.org/wiki/Patrick_Collison

The Biotech Startups Podcast is handcrafted by our friends over at: fame.so